Internal Medicine, Cardiovascular Disease · Imperial, CA
NPI
1649224387
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
516 West Aten Road, Suite 1
Imperial, CA, 92251
Phone (760) 355-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
38,413 services
Medicare patients, 2024
3,256
Average age 75
Drug cost, 2024
$3.6M
16,792 prescriptions
Company payments, 2025
$34.17
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vachaspathi Palakodeti was code 99490 (chronic, principal, and transitional care management), 6,728 times for 914 patients. In total Vachaspathi Palakodeti billed 38,413 services in 108 codes, and Medicare paid $2.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 6,728 | 914 | $49.19 | $331K |
| 99457 E&M - Miscellaneous | Office | 4,979 | 853 | $38.16 | $190K |
| 99454 E&M - Miscellaneous | Office | 3,756 | 659 | $37.89 | $142K |
| 99214 Office E&M - Established | Office | 3,687 | 1,922 | $97.63 | $360K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,852 | 461 | $5.54 | $10K |
| 93306 Echocardiography (TTE/TEE) | Office | 1,660 | 1,577 | $150.37 | $250K |
| 93010 Electrocardiogram | Office | 1,462 | 1,197 | $6.29 | $9,198 |
| 93005 Electrocardiogram | Office | 1,462 | 1,197 | $5.22 | $7,629 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 1,030 | 515 | $64.72 | $67K |
| 93298 External Electrocardiographic Monitoring | Office | 604 | 101 | $67.77 | $41K |
| 93018 Electrocardiogram | Office | 603 | 594 | $10.80 | $6,511 |
| 93016 Electrocardiogram | Office | 603 | 594 | $16.40 | $9,888 |
| 93017 Electrocardiogram | Office | 602 | 593 | $24.66 | $15K |
| 93296 External Electrocardiographic Monitoring | Office | 600 | 214 | $17.16 | $10K |
| 99213 Office E&M - Established | Office | 584 | 512 | $70.32 | $41K |
By year: 2022 $2.0M for 50,798 services; 2023 $2.2M for 45,901 services; 2024 $2.2M for 38,413 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 151 | 14 | $4.20 | $634 |
Medicare prescription drug claims, 2024
In 2024, the drug Vachaspathi Palakodeti prescribed most often to Medicare patients was Metoprolol Succinate, with 2,202 prescriptions and refills. In total Vachaspathi Palakodeti wrote 16,792 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 2,202 | 4,709 | 746 | $34K |
| Atorvastatin Calcium Generic | 1,396 | 3,193 | 552 | $13K |
| Entresto Sacubitril/Valsartan | 1,019 | 1,525 | 262 | $969K |
| Eliquis Apixaban | 975 | 1,752 | 302 | $989K |
| Furosemide Generic | 846 | 1,550 | 304 | $3,047 |
| Amlodipine Besylate Generic | 769 | 1,695 | 295 | $4,457 |
| Xarelto Rivaroxaban | 655 | 1,176 | 185 | $633K |
| Rosuvastatin Calcium Generic | 640 | 1,477 | 244 | $13K |
| Losartan Potassium Generic | 594 | 1,240 | 222 | $4,358 |
| Carvedilol Generic | 589 | 1,312 | 213 | $5,222 |
| Metoprolol Tartrate Generic | 459 | 982 | 186 | $2,905 |
| Clopidogrel Clopidogrel Bisulfate | 450 | 1,044 | 166 | $5,646 |
| Lisinopril Generic | 449 | 1,036 | 178 | $2,690 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 404 | 822 | 138 | $5,468 |
| Jardiance Empagliflozin | 374 | 658 | 109 | $358K |
Brand drugs: - claims; generic drugs: 12,821 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vachaspathi Palakodeti $34.17 ($34.17 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $20.7.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.